| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |